Short QT syndrome type 3: genes and variants

Explore variant evidence for Short QT syndrome type 3 across 3 analyzed proteins (KCNJ2, KCNH2, KCNQ1). Linked ClinVar records include 36 pathogenic or likely pathogenic variants, 222 variants of uncertain significance and 27 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Short QT syndrome type 3

Where Short QT syndrome type 3 variants cluster

ClinVar pathogenic and likely pathogenic variants linked to Short QT syndrome type 3

VariantPositionProtein partClinical label
KCNJ2 G144S144Pore-formingPathogenic / likely pathogenic (★★)
KCNJ2 T75M75CytoplasmicPathogenic / likely pathogenic (★★)
KCNJ2 G144A144Pore-formingPathogenic / likely pathogenic (★★)
KCNJ2 G144D144Pore-formingPathogenic / likely pathogenic (★★)
KCNJ2 R218W218CytoplasmicPathogenic / likely pathogenic (★★)
KCNJ2 R218P218CytoplasmicPathogenic / likely pathogenic (★★)
KCNJ2 R218L218CytoplasmicPathogenic / likely pathogenic (★★)
KCNJ2 R82Q82TransmembranePathogenic / likely pathogenic (★★)
KCNJ2 M307V307CytoplasmicPathogenic / likely pathogenic (★★)
KCNJ2 R312C312CytoplasmicPathogenic / likely pathogenic (★★)
KCNJ2 G146S146Pore-formingPathogenic / likely pathogenic (★★)
KCNQ1 R259H259CytoplasmicPathogenic / likely pathogenic (★★)
KCNQ1 R539W539Interaction with KCNE1 C-terminusPathogenic / likely pathogenic (★★)
KCNJ2 R189G189Polyphosphoinositide (PIP2)-bindingPathogenic / likely pathogenic (★★)
KCNJ2 M301R301CytoplasmicPathogenic / likely pathogenic (★★)
KCNH2 N629S629Segment H5Pathogenic / likely pathogenic (★★)
KCNJ2 R67Q67CytoplasmicPathogenic / likely pathogenic (★★)
KCNQ1 R507W507CytoplasmicPathogenic / likely pathogenic (★★)
KCNJ2 T75K75CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 T75R75CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 D78Y78CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 D78N78CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 T309I309CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 Y145C145Pore-formingPathogenic / likely pathogenic (★)
KCNJ2 G215D215CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 N216Y216CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 R260H260CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 D71V71CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 D172N172TransmembranePathogenic / likely pathogenic (★)
KCNJ2 P186Q186Polyphosphoinositide (PIP2)-bindingPathogenic / likely pathogenic (★)
KCNJ2 E299G299CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 T305A305CytoplasmicPathogenic / likely pathogenic (★)
KCNH2 Y43D43PASPathogenic / likely pathogenic (★)
KCNH2 G47V47PASPathogenic / likely pathogenic (★)
KCNH2 L86R86CytoplasmicPathogenic / likely pathogenic (★)
KCNQ1 F279I279Segment S5Pathogenic / likely pathogenic

Uncertain variants prioritized for review in Short QT syndrome type 3

VariantPositionProtein partClinical labelEvidence
KCNJ2 M301V301CytoplasmicConflicting reports (★)+7: 2 other pathogenic changes within 3 positions; M301R at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.861
KCNJ2 G144V144Pore-formingConflicting reports (★)+6: 5 other pathogenic changes within 3 positions; G144A at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
KCNJ2 R189K189Polyphosphoinositide (PIP2)-bindingConflicting reports (★)+6: 2 other pathogenic changes within 3 positions; R189G at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99
KCNJ2 M301L301CytoplasmicConflicting reports (★)+6: 2 other pathogenic changes within 3 positions; M301R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.72
KCNJ2 G215C215CytoplasmicUncertain (★)+6: 5 other pathogenic changes within 3 positions; G215D at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98
KCNJ2 G146D146Pore-formingUncertain (★)+6: 5 other pathogenic changes within 3 positions; G146S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
KCNJ2 D78H78CytoplasmicUncertain (★)+6: 5 other pathogenic changes within 3 positions; D78Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
KCNJ2 N216I216CytoplasmicUncertain (★)+6: 5 other pathogenic changes within 3 positions; N216Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99
KCNJ2 R189T189Polyphosphoinositide (PIP2)-bindingUncertain (★)+6: 2 other pathogenic changes within 3 positions; R189G at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00

Which prediction tools work for Short QT syndrome type 3

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Short QT syndrome type 3

Frequently asked questions

Which genes have records linked to Short QT syndrome type 3?

This view contains 3 analyzed proteins: KCNJ2, KCNH2, KCNQ1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 36 pathogenic or likely pathogenic variants, 222 variants of uncertain significance and 27 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 9 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 300 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center